Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy-Reference-Cited by-同舟云学术

Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy

Published:2010-04 Issue:4 Volume:16 Page:548-554
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Nemec Pavel,Zemanova Zuzana,Greslikova Henrieta,Michalova Kyra,Filkova Hana,Tajtlova Jana,Kralova Dana,Kupska Renata,Smetana Jan,Krejci Marta,Pour Ludek,Zahradova Lenka,Sandecka Viera,Adam Zdenek,Buchler Tomas,Spicka Ivan,Gregora Evzen,Kuglik Petr,Hajek Roman

Funder

Masaryk University

Ministry of Education

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Single versus double autologous stem-cell transplantation for multiple myeloma;Attal;N Engl J Med,2003

2. Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol;Moreau;Blood,2006

3. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial;Palumbo;Lancet,2006

4. MMY-3002: a phase 3 study comparing bortezomib-melphalan-prednisone (VMP) with melphalan-prednisone (MP) in newly diagnosed multiple myeloma;San Miguel;Blood,2007

5. Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics;Cremer;Genes Chromosomes Cancer,2005

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients;Journal of Clinical Laboratory Analysis;2024-09-12

2. Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells;Blood Cancer Journal;2024-06-07

3. The numerous facets of 1q21⁺ in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review);Oncology Letters;2024-04-09

4. 1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study;Annals of Hematology;2024-01-11

5. Cytogenetic findings in testicular relapse of multiple myeloma: case report and literature review;Hematology, Transfusion and Cell Therapy;2024-01